TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2017

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of a randomized, double-blind, phase 3 trial versus oral palonosetron.

Matti Aapro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.